MERCK & CO. INC. (MRK) Stock Price, Quote, News and Overview
NYSE:MRK - New York Stock Exchange, Inc. - US58933Y1055 - Common Stock - Currency: USD
MRK Quote, Performance and Key Statistics
78
+1.54 (+2.01%)
The current stock price of MRK is 78 USD. In the past month the price decreased by -17.66%. In the past year, price decreased by -37.99%.
MRK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 64.61 | 796.27B | ||
| JNJ | JOHNSON & JOHNSON | 15.67 | 379.48B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 16.83 | 257.82B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.96 | 218.96B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.29 | 209.55B | ||
| PFE | PFIZER INC | 7.12 | 125.57B | ||
| SNY | SANOFI-ADR | 11.41 | 124.61B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.18 | 100.17B | ||
| GSK | GSK PLC-SPON ADR | 8.32 | 72.88B | ||
| ZTS | ZOETIS INC | 25.11 | 66.32B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.98 | 46.47B | ||
| HLN | HALEON PLC-ADR | 21.29 | 46.14B |
Related stock screener links
About MRK
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Kenilworth, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
Company Info
MERCK & CO. INC.
2000 Galloping Hill Road
Kenilworth NEW JERSEY 07033 US
CEO: Kenneth C. Frazier
Employees: 75000
Company Website: https://www.merck.com/
Investor Relations: https://www.merck.com/investor-relations
Phone: 19087404000
MERCK & CO. INC. / MRK FAQ
What is the stock price of MERCK & CO. INC. today?
The current stock price of MRK is 78 USD. The price increased by 2.01% in the last trading session.
What is the ticker symbol for MERCK & CO. INC. stock?
The exchange symbol of MERCK & CO. INC. is MRK and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is MRK stock listed?
MRK stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for MERCK & CO. INC. stock?
29 analysts have analysed MRK and the average price target is 116.89 USD. This implies a price increase of 49.85% is expected in the next year compared to the current price of 78. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MERCK & CO. INC. worth?
MERCK & CO. INC. (MRK) has a market capitalization of 196.28B USD. This makes MRK a Large Cap stock.
How many employees does MERCK & CO. INC. have?
MERCK & CO. INC. (MRK) currently has 75000 employees.
What are the support and resistance levels for MERCK & CO. INC. (MRK) stock?
MERCK & CO. INC. (MRK) has a resistance level at 91.54. Check the full technical report for a detailed analysis of MRK support and resistance levels.
Is MERCK & CO. INC. (MRK) expected to grow?
The Revenue of MERCK & CO. INC. (MRK) is expected to grow by 1.66% in the next year. Check the estimates tab for more information on the MRK EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MERCK & CO. INC. (MRK) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MRK, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MRK, evaluating the profitability, health, valuation and growth aspects
- MERCK & CO. INC. (MRK) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MERCK & CO. INC. (MRK) Sales and EPS estimates to see what analysts future expectations are.
- MERCK & CO. INC. (MRK) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MERCK & CO. INC. (MRK) Insider and Institutional Ownership to learn about the owners and their transactions.
- MERCK & CO. INC. (MRK) Stock Chart to make your own analysis
- MERCK & CO. INC. (MRK) Latest news and press-releases to stay up to date.
Does MERCK & CO. INC. (MRK) stock pay dividends?
MERCK & CO. INC. (MRK) has a dividend yield of 4.18%. The yearly dividend amount is currently 3.1. Check the full fundamental report for a detailed analysis of MRK dividend history, reliability and sustainability.
When does MERCK & CO. INC. (MRK) report earnings?
MERCK & CO. INC. (MRK) will report earnings on 2025-04-24, before the market open.
What is the Price/Earnings (PE) ratio of MERCK & CO. INC. (MRK)?
The PE ratio for MERCK & CO. INC. (MRK) is 10.21. This is based on the reported non-GAAP earnings per share of 7.64 and the current share price of 78 USD. Check the full fundamental report for a full analysis of the valuation metrics for MRK.
What is the Short Interest ratio of MERCK & CO. INC. (MRK) stock?
The outstanding short interest for MERCK & CO. INC. (MRK) is 1.63% of its float. Check the ownership tab for more information on the MRK short interest.
MRK Technical Analysis
MRK Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MRK. MRK has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
MRK Financial Highlights
Over the last trailing twelve months MRK reported a non-GAAP Earnings per Share(EPS) of 7.64. The EPS increased by 409.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.68% | ||
| ROA | 14.62% | ||
| ROE | 36.96% | ||
| Debt/Equity | 0.74 |
MRK Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to MRK. The Buy consensus is the average rating of analysts ratings from 29 analysts.
For the next year, analysts expect an EPS growth of 18.8% and a revenue growth 1.66% for MRK